 |
|
Biomarker Services
|
|
In collaboration with the clinical team, SGS has actively pursued the assay development & validation of innovative biomarkers. We have coupled RIA with HPLC to secure further selectivity in biomarker analysis and have developed LC-MS/MS methodologies to measure steroidal and hormonal substances in the low picogram range. We have also invested in the field of multiplexing, using the platform (Biorad Bioplex 200). Biomarker development for various therapeutic areas includes:
|
|||||||||||||||||||||||||||
